Mandate

Vinge has advised Azelio in connection with its rights issue

Vinge has advised Azelio AB (publ) on a fully guaranteed rights issue, which will provide Azelio with issue proceeds amounting to approximately SEK 300 million before deduction of transaction costs.

The new shares and warrants issued by reason of the rights issue are expected to be admitted to trading on Nasdaq First North Growth Market on 31 October 2022.

Azelio is a public Swedish company, specializing in in energy storage with electricity and heat production. Azelio’s system (“TES.POD “) for renewable, Stirling-based electricity production and heat production is based on continuous technological development and refinement. The technology makes the energy dispatchable, enabling renewable energy to be made available around-the-clock.

Azelio’s shares are listed on Nasdaq First North Growth Market.

Vinge’s team consisted primarily of David Andersson, William Kåge, Joel Magnusson, Benjamin Vafaeian and Joacim Malmqvist.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025